You just read:

OncoSec Presents Clinical Overview of Comprehensive Immune Monitoring Data Demonstrating Conversion of "Cold" Tumors to "Hot" Tumors with ImmunoPulse® IL-12 and Pembrolizumab Combination Therapy

News provided by

OncoSec Medical Incorporated

Sep 27, 2017, 08:00 ET